The market has been volatile in the last few months as the Federal Reserve finalized its rate cuts and uncertainty looms over trade negotiations with China. Small cap stocks have been hit hard as a result, as the Russell 2000 ETF (IWM) has underperformed the larger S&P 500 ETF (SPY) by more than 10 percentage […]
SOUTH SAN FRANCISCO, Calif., April 30, 2020 -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today announced that it will host a conference call on Thursday, May 7th, 2020 at.
Phase 1b/2 Trial of Vecabrutinib in 400 mg Cohort; Clinical Update at Upcoming ASH Annual Meeting Sunesis to Host Conference Call Today at 4:30 PM Eastern Time SOUTH SAN.
SOUTH SAN FRANCISCO, Calif., Feb. 25, 2020 -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today announced that Willie Quinn, Chief Financial Officer and Senior Vice President,.
Sunesis Pharmaceuticals, Inc. (SNSS) today announced that it will host a conference call on Tuesday, November 12th, 2019 at 4:30 p.m. Eastern Time to discuss corporate updates and financial results for the third quarter ended September 30, 2019.
Is (SNSS) Outperforming Other Medical Stocks This Year?
SOUTH SAN FRANCISCO, Calif., March 03, 2020 -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today announced that it will host a conference call on Tuesday, March 10, 2020 at.
SOUTH SAN FRANCISCO, Calif., Nov. 08, 2019 -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today announced that Willie Quinn, Chief Financial Officer and Senior Vice President,.
Q4 2019 Sunesis Pharmaceuticals Inc Earnings Call
SOUTH SAN FRANCISCO, Calif., May 07, 2020 -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today reported financial results for the first quarter ended March 31, 2020. Loss from.
SOUTH SAN FRANCISCO, Calif., Nov. 06, 2019 -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today announced a poster presentation at the 61st American Society of Hematology.
Is (SNSS) Outperforming Other Medical Stocks This Year?
Q3 2019 Sunesis Pharmaceuticals Inc Earnings Call
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks hitting 52-week highs on Dec. 5) ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD )(presented ...
SOUTH SAN FRANCISCO, Calif., March 10, 2020 -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today reported financial results for the fourth quarter and year ended December 31,.
Biotech stocks went back and forth but managed to end the week with a gain. As usual, some stocks swung wildly in reaction to catalysts, primarily clinical readouts. Aurinia Pharmaceuticals Inc (NASDAQ: ...
NEW YORK, NY / ACCESSWIRE / March 10, 2020 / Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) will be discussing their earnings results in their 2019 Fourth Quarter Earnings call to be held on March 10, 2020 ...
Q1 2020 Sunesis Pharmaceuticals Inc Earnings Call
SOUTH SAN FRANCISCO, Calif., Dec. 05, 2019 -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today announced data from the Company’s Phase 1b/2 clinical trial of its non-covalent.
Shareholders in Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) had a terrible week, as shares crashed 62% to US$0.38 in...